We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Five guidance statements on testing chemicals with no or inadequate genotoxicity data.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
It's illegal to drive if you're unfit to do so because you're on legal or illegal drugs, or you have certain levels of drugs or medicine in your blood
A range of tests are available from the majority of PHE regional clinical microbiology laboratories.
Information to assist with the laboratory diagnosis of Lyme disease and requirements for sample submission.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to carry out a risk assessment if you are applying for a bespoke permit that includes discharging hazardous chemicals and elements to surface water.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
DASA has launched a new Themed Competition looking for innovations that can enhance the testing of drug drivers
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Guidance for local authorities, port health authorities and food traders on how to submit a sample for referee analysis.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
The NHSBT and UKHSA surveillance programme is a series of national schemes that monitors infection in blood, tissue and organ donors, and transfusion recipients.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Find out how to take samples from processed ABPs and find laboratories to test them, and what to do if one of your samples fails a test.
AVU provides services for genotypic antiviral resistance testing of HIV and HCV, investigation of HIV transmission events and HSV antiviral resistance testing by phenotyping.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).